We are live on
!
Find out more
ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
129 hedge funds and large institutions have $545M invested in Array Biopharma Inc in 2014 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 41 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 12
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
6% more funds holding
Funds holding: 122 → 129 (+7)
2% more capital invested
Capital invested by funds: $532M → $545M (+$12.3M)
12% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 41
60% less call options, than puts
Call options by funds: $1.42M | Put options by funds: $3.55M
Holders
129
Holders Change
+7
Holders Change %
+5.74%
% of All Funds
3.71%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.14%
New
20
Increased
36
Reduced
41
Closed
12
Calls
$1.42M
Puts
$3.55M
Net Calls
-$2.13M
Net Calls Change
+$1.05M
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$25.8M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$13.2M |
| 3 |
AC
Apex Capital
Orinda,
California
|
+$4.96M |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$1.4M |
| 5 |
CNB
City National Bank
Beverly Hills,
California
|
+$1.39M |
